Amphastar Pharmaceuticals (AMPH) Acquisitions (2014 - 2016)

Amphastar Pharmaceuticals' Acquisitions history runs 3 years deep, the most recent figure standing at $3.4 million for Q4 2016.

• In Q4 2016, Acquisitions fell 2.86% year-over-year to $3.4 million; the TTM figure through Dec 2016 stood at $11.7 million (changed N/A YoY), while the FY2016 annual figure was $12.5 million, up 256.03% from the prior year.
• Acquisitions was $3.4 million for Q4 2016 at Amphastar Pharmaceuticals, up from $761000.0 in the prior quarter.
• In the past five years, Acquisitions ranged from a high of $6.0 million in Q4 2014 to a low of $761000.0 in Q2 2016.
• Historically, Acquisitions has averaged $3.5 million across 3 years, with a median of $3.5 million in 2015.
• The sharpest annual moves came in 2015 and 2016: Acquisitions slumped 41.67% in 2015, then fell 2.86% in 2016.
• A 3-year view of Acquisitions shows it stood at $6.0 million in 2014, then slumped by 41.67% to $3.5 million in 2015, then declined by 2.86% to $3.4 million in 2016.
• The last three Acquisitions figures came in at $3.4 million (Q4 2016), $761000.0 (Q2 2016), and $4.0 million (Q1 2016), per Business Quant data.